N-alkyloxycarbonyl derivatives of ethylene diamine as monoamine oxidase inhibitors

Journal of Neural Transmission, Supplement

Volumn , Issue 52, 1998, Pages 351-355

  Pozdnev, V F ^a   Kirkel, A Z ^b   Kamyshanskaya, N S ^a   Axenova, L N ^b   Medvedev, A E ^a  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^b INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ETHYLENEDIAMINE DERIVATIVE; MONOAMINE OXIDASE A INHIBITOR; MONOAMINE OXIDASE B INHIBITOR; AMINE OXIDASE (FLAVIN CONTAINING); ISOENZYME; MONOAMINE OXIDASE INHIBITOR;

ANIMAL CELL; ARTICLE; BRAIN MITOCHONDRION; DRUG SELECTIVITY; DRUG SYNTHESIS; ENZYME INHIBITION; LIVER MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; RAT; STRUCTURE ACTIVITY RELATION; ANIMAL; BRAIN; CHEMISTRY; DRUG ANTAGONISM; ENZYMOLOGY; KINETICS; METABOLISM; MITOCHONDRION; SYNTHESIS;

ANIMALS; BRAIN; ETHYLENEDIAMINES; ISOENZYMES; KINETICS; MITOCHONDRIA; MITOCHONDRIA, LIVER; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; RATS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0031596705     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6499-0_38     Document Type: Article

References (12)

1. Annan N, Silverman RB (1993) New analogues of N-(2-Aminoethyl)-4- chlorobenzamide (Ro 16-6491). Some of the most potent monoamine oxidase-B inactivators. J Med Chem 36: 3968-3970
2. Burrows CD, Da Prada M (eds) (1989) Reversible MAO A inhibitors as antidepressants. J Neural Transm 28 [Suppl]: 1-106
3. Cesura AM, Pletscher A (1992) The new generation of monoamine oxidase inhibitors. Prog Drug Res 38: 171-297
4. Cesura AM, Galva MD, Imhof R, Kubez E, Picotti GB, Da Prada M (1989) [3H]Ro 19-6327: a reversible ligand and affinity labelling probe for monoamine oxidase-B. Eur J Pharmacol 162: 457-465
5. Cesura AM, Kettler R, Imhof R, Da Prada M (1992) Mode of action and characteristics of monoamine oxidase-A inhibition by moclobemide. Psychopharmacology 106: SIS-816
6. Da Prada M, Kettler R, Keller HH, Burkland \VP, Haefely WE (1989) Preclinical profiles of the novel reversible MAO-A inhibitors, moclobemide and brofaromine, in comparison with irreversible MAO inhibitors. J Neural Transm 28 [Suppl]: 5-20
7. Gorkin VZ (1983) Aminé oxidases in clinical research. Pergamon Press, Oxford Medvedev AE, Kirkel AZ, Kamyshanskaya NS, Axenova LN, Moskvitina TA, Gorkin VZ, Andreeva NI, Mashkovsky MD (1994) Monoamine oxidase inhibition by novel antidepressant tetrindole. Biochem Pharmacol 47: 303-308
8. Pozdnev VF, Nuzhnova IA (1976) Preparation of carbonic acid derivatives for peptide synthesis from alkyloxycarboxyl salts. Zh Organ Khim (Russ) 12: 1407-1410
9. Pozdnev VF, Smirnova EA, Podgornova NN, Zencova NK, Kalejs UO (1979) Synthesis of di-tert-butyl pyrocarbonate from carboxylic acid chloroanhydrides. Zh Organ Khim 15: 106-109
10. Shih J (1993) cDNA cloning of human liver MAO-A and MAO-B. In: Yasuhara H, Parvez H, Oguchi K, Sandier M, Nagatsu T (eds) Monoamine oxidase: basic and clinical aspects. VSP, Utrecht, pp 15-22
11. Tetrud VW, Lanston JW (1989) The effect of deprenyl (selegiline) on the natural history of Parkinson's disease. Science (Washington DC) 245: 519-522
12. Tipton KF, Youdim MBH (1976) Assay of monoamine oxidase. In: Wolstenholm GEW, Knight J (eds) Monoamine oxidase and its inhibition. Elsevier, Amsterdam, pp 393-403